Your browser is no longer supported. Please, upgrade your browser.
QGEN [NYSE]
QIAGEN N.V.
Index- P/E34.39 EPS (ttm)1.53 Insider Own3.60% Shs Outstand228.57M Perf Week2.53%
Market Cap12.19B Forward P/E22.95 EPS next Y2.30 Insider Trans0.00% Shs Float217.69M Perf Month8.66%
Income359.20M PEG2.19 EPS next Q0.63 Inst Own70.20% Short Float2.08% Perf Quarter-1.20%
Sales1.87B P/S6.52 EPS this Y938.90% Inst Trans13.47% Short Ratio5.16 Perf Half Y0.50%
Book/sh12.24 P/B4.30 EPS next Y-7.64% ROA6.50% Target Price58.81 Perf Year31.30%
Cash/sh3.09 P/C17.04 EPS next 5Y15.68% ROE13.50% 52W Range39.93 - 59.00 Perf YTD-0.30%
Dividend- P/FCF37.50 EPS past 5Y22.00% ROI6.50% 52W High-11.06% Beta0.26
Dividend %- Quick Ratio2.20 Sales past 5Y7.90% Gross Margin65.90% 52W Low31.42% ATR1.07
Employees5610 Current Ratio2.70 Sales Q/Q38.10% Oper. Margin20.70% RSI (14)61.62 Volatility1.56% 1.60%
OptionableYes Debt/Eq0.69 EPS Q/Q359.10% Profit Margin19.20% Rel Volume0.57 Prev Close52.69
ShortableYes LT Debt/Eq0.67 EarningsFeb 09 AMC Payout0.00% Avg Volume877.50K Price52.47
Recom2.50 SMA204.95% SMA502.92% SMA2004.28% Volume212,461 Change-0.41%
Oct-06-20Resumed BofA Securities Buy $59
Sep-28-20Upgrade Kepler Hold → Buy
Aug-24-20Upgrade Citigroup Neutral → Buy $48 → $62
Aug-20-20Resumed JP Morgan Overweight $60
Aug-17-20Upgrade Berenberg Hold → Buy
Aug-14-20Upgrade Exane BNP Paribas Neutral → Outperform
Aug-14-20Upgrade Deutsche Bank Hold → Buy
Mar-04-20Downgrade Berenberg Buy → Hold
Jan-08-20Initiated Wells Fargo Equal Weight $36
Jan-07-20Initiated Citigroup Neutral $35
Dec-26-19Resumed BofA/Merrill Underperform $28
Nov-15-19Initiated Stifel Hold
Nov-14-19Upgrade Kepler Reduce → Hold
Nov-14-19Upgrade JP Morgan Underweight → Overweight
Nov-14-19Upgrade Evercore ISI In-line → Outperform
Oct-17-19Upgrade Wolfe Research Peer Perform → Outperform
Oct-09-19Downgrade Kepler Hold → Reduce
Oct-08-19Downgrade JP Morgan Neutral → Underweight
Oct-08-19Downgrade Deutsche Bank Buy → Hold
Oct-08-19Downgrade Barclays Overweight → Equal Weight
Apr-08-21 11:40AM  
09:36AM  
07:17AM  
Apr-07-21 09:59AM  
08:04AM  
Apr-06-21 04:05PM  
Apr-01-21 07:51AM  
Mar-29-21 08:38AM  
02:00AM  
Mar-16-21 11:40AM  
Mar-09-21 08:58AM  
Mar-05-21 04:58PM  
06:05AM  
Mar-03-21 04:10PM  
08:57AM  
Mar-02-21 04:11PM  
Feb-24-21 01:45AM  
01:45AM  
Feb-22-21 04:08PM  
Feb-10-21 09:00PM  
11:30AM  
10:18AM  
07:15AM  
Feb-09-21 05:48PM  
05:45PM  
04:05PM  
Feb-08-21 04:32PM  
10:18AM  
Feb-03-21 12:47PM  
Feb-02-21 12:31PM  
Jan-28-21 04:05PM  
Jan-26-21 10:00AM  
07:10AM  
Jan-20-21 04:08PM  
04:05PM  
Jan-14-21 01:52PM  
11:51AM  
Jan-13-21 09:52AM  
Jan-08-21 07:00AM  
07:00AM  
Jan-07-21 04:25PM  
Jan-01-21 11:16AM  
Dec-23-20 07:29PM  
Dec-21-20 09:33AM  
09:16AM  
Dec-17-20 04:05PM  
Dec-11-20 06:02PM  
Dec-08-20 10:18AM  
01:45AM  
Dec-07-20 02:00AM  
Nov-25-20 09:45AM  
Nov-23-20 02:28PM  
Nov-19-20 11:08AM  
Nov-18-20 04:05PM  
Nov-17-20 10:21AM  
10:09AM  
Nov-16-20 04:05PM  
10:20AM  
Nov-13-20 08:30AM  
Nov-12-20 01:11PM  
Nov-11-20 04:05PM  
Nov-09-20 03:52PM  
Oct-28-20 12:06PM  
Oct-27-20 03:05PM  
01:04PM  
12:59PM  
Oct-19-20 01:28PM  
Oct-16-20 09:00AM  
08:46AM  
Oct-15-20 09:00AM  
Oct-14-20 08:30AM  
Oct-13-20 08:45AM  
Oct-12-20 09:00AM  
08:48AM  
Oct-08-20 11:30AM  
08:38AM  
Oct-06-20 01:01PM  
12:53PM  
Oct-05-20 04:03PM  
Oct-02-20 12:00PM  
Sep-22-20 11:30AM  
Sep-18-20 09:02AM  
Sep-17-20 04:05PM  
Sep-16-20 09:55AM  
Sep-14-20 11:14PM  
09:41AM  
Sep-10-20 09:39AM  
Sep-09-20 10:23AM  
Sep-08-20 04:02PM  
08:59AM  
Sep-04-20 11:30AM  
Sep-03-20 11:31AM  
Aug-25-20 03:40PM  
09:19AM  
02:17AM  
Aug-24-20 04:02PM  
12:40PM  
Aug-21-20 11:52AM  
Aug-19-20 10:20AM  
Aug-18-20 04:05PM  
QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. The company offers primary sample technology consumables, such as nucleic stabilization and purification kits designed for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay (IGRA) for TB testing, and assays for post-transplant testing and viral load monitoring; assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and assays for prenatal testing and detection of sexually transmitted diseases and HPV; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers PCR consumables, such as quantitative PCR, reverse transcription and combinations kits for analysis of gene expression, genotyping and gene regulation instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR solutions; and developed and configured OEM consumables. It offers predefined and custom NGS gene panels, library prep kits and components, whole genome amplification, etc.; bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. The company has collaboration agreements with Amgen Inc.; CLIA-certified laboratories; NuProbe Global; and Personal Genome Diagnostics Inc. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.